COMPANY
Radiomer Therapeutics
Radiomer Therapeutics, Inc. is developing Radiomers, targeted radiopharmaceuticals / radioligand therapies, for theranostic applications using its Raptamer platform. From company website Source · checked 2026-10-19
Sources for this description (1)
- Radiomer Therapeutics, Inc. is developing Radiomers, targeted radiopharmaceuticals / radioligand therapies, for theranostic applications using its Raptamer platform.
- “Radiomer Therapeutics, Inc. is developing Radiomers, targeted radiopharmaceuticals / radioligand therapies, for theranostic applications using its novel Raptamer platform.” https://www.radiomer.com/about (2026-10-19)